LexisNexis Risk Solutions recently completed an agreement with its sister company Elsevier to transfer MEDai, its clinical-analytics-focused business unit, to the LexisNexis healthcare business. LexisNexis Risk Solutions and Elsevier are both part of Reed Elsevier Group plc.
The combined organisation will allow LexisNexis to offer a more comprehensive set of cost-containment solutions to curtail wasteful spending, help coordinate better care, improve population health management, enhance clinical outcomes and reduce exposure to fraud, waste and abuse (FWA).
This announcement comes as healthcare organizations strive to accomplish three critical goals driven by the Affordable Care Act (ACA) - improve access to healthcare, improve outcomes and reduce overall costs. In order to achieve progress against these priorities, many payer and provider organisations are deploying technology at an enterprise level to address and align the needs of various operational workflows.
This transfer follows LexisNexis' fall 2012 acquisition of EDIWatch, a provider of fraud, waste and abuse (FWA) technology solutions exclusively for the healthcare payer industry. Through that acquisition, LexisNexis added products to address FWA detection, recovery, and prevention while leveraging automated business fraud rules and analytics and adding user-friendly case management workflow tools and investigatory services.
